SEARCH HEALTH CONDITIONS BY ALPHABETS
Factor VII Deficiency
Medications for Factor VII Deficiency
Other names: Extrinsic factor deficiency
About Factor VII Deficiency: Factor VII deficiency is a disease when a deficiency of plasma protein factor VII contributes to abnormal bleeding.
Drugs Used to Treat Factor VII Deficiency
The following list of medications come used at the treating this illness, or somehow related to.
Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
NovoSeven RT | Rx | C | N | Insert review | 0.0 | ||
Generic name: coagulation factor viia systemic Medication course: miscellaneous coagulation modifiers For users: dose, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
coagulation factor viia | Rx | C | N | Insert review | 0.0 | ||
Generic name: coagulation factor viia systemic Brand name: NovoSeven RT Medication course: miscellaneous coagulation modifiers For users: dose, interactions, For professionals: Az Drug Truth, AHFS DI Monograph | |||||||
variable ix complex | Rx | C | N | Insert review | 0.0 | ||
Generic name: variable ix complex systemic Brand names: Profilnine SD, Bebulin Medication course: miscellaneous coagulation modifiers For users: dose, interactions, For professionals: Az Drug Truth | |||||||
Profilnine SD | Rx | C | N | Insert review | 0.0 | ||
Generic name: variable ix complex systemic Medication course: miscellaneous coagulation modifiers For users: dose, interactions, side effects For professionals: Prescribing Information | |||||||
Bebulin | Rx | C | N | Insert review | 0.0 | ||
Generic name: variable ix complex systemic For users: dose, interactions, negative effects | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | On the Counter |
Rx/OTC | Prescription or Over the Counter |
Away Prizes | This drug might well not be approved by the FDA for the treatment of this illness. |
Pregnancy Category | |
---|---|
A | sufficient and well-controlled studies have failed to present a risk to the fetus in the first trimester of pregnancy (and there`s absolutely no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may justify use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks entailed in use in pregnant women certainly outweigh potential rewards. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | Is not subject to the Controlled Substances Act. |
Inch | features a high potential for abuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
2 | features a high potential for abuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may lead to acute emotional or physical dependence. |
3 | includes a possibility for abuse less than people in programs 1 and 2 two. Has a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | features a low potential for abuse in accordance with people in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
5 | features a low potential for abuse in accordance with people in program 4. Has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 4. |
Infection | |
---|---|
X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always ask your physician to be sure the information displayed on these pages applies to your circumstances.
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Popular Categories
Health Condition
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar